Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Sponsor: Medical University of South Carolina

Sponsor score: 0
Inactive

ClinicalTrials ID:NCT07149207

Patient View

This clinical trial evaluates the use of Indocyanine Green (ICG) dye to enhance tumor visualization during surgery in adults with head and neck squamous cell carcinoma. Eligible participants are those aged 18 and older, who are good operative candidates and can provide informed consent. The intervention involves a 5 mg/kg IV injection of ICG prior to surgery, with participation lasting approximately 6 weeks.

Patient Parameters

Program Overview

This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.

Eligibility Criteria

Inclusion Criteria

  • Adults ≥18 years
  • Squamous cell carcinoma of head and neck mucosal origin
  • Good operative candidate
  • Capable of giving informed consent

Exclusion Criteria

  • Pregnant women
  • Known allergy to iodides or shellfish
  • Currently incarcerated individuals

Get This Program In Your Inbox

You can sign up and apply your patients for this program.